ATE430801T1 - Von wd-40 abstammende peptide und ihre verwendung - Google Patents
Von wd-40 abstammende peptide und ihre verwendungInfo
- Publication number
- ATE430801T1 ATE430801T1 AT95911591T AT95911591T ATE430801T1 AT E430801 T1 ATE430801 T1 AT E430801T1 AT 95911591 T AT95911591 T AT 95911591T AT 95911591 T AT95911591 T AT 95911591T AT E430801 T1 ATE430801 T1 AT E430801T1
- Authority
- AT
- Austria
- Prior art keywords
- protein
- activity
- region
- peptides derived
- interacts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4722—G-proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/190,802 US5519003A (en) | 1994-02-01 | 1994-02-01 | WD-40-derived peptides and uses thereof |
PCT/US1995/001210 WO1995021252A2 (en) | 1994-02-01 | 1995-01-31 | Wd-40-derived peptides and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE430801T1 true ATE430801T1 (de) | 2009-05-15 |
Family
ID=22702844
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT95911591T ATE430801T1 (de) | 1994-02-01 | 1995-01-31 | Von wd-40 abstammende peptide und ihre verwendung |
Country Status (7)
Country | Link |
---|---|
US (2) | US5519003A (de) |
EP (1) | EP0742824B1 (de) |
JP (1) | JPH09511390A (de) |
AT (1) | ATE430801T1 (de) |
CA (1) | CA2182299A1 (de) |
DE (1) | DE69535948D1 (de) |
WO (1) | WO1995021252A2 (de) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3563091B2 (ja) * | 1993-08-03 | 2004-09-08 | 第一サントリーファーマ株式会社 | 酸化リン脂質分解酵素およびその遺伝子 |
US5519003A (en) | 1994-02-01 | 1996-05-21 | Board Of Trustees Of The Leland Stanford Junior University | WD-40-derived peptides and uses thereof |
US6262023B1 (en) | 1994-02-01 | 2001-07-17 | The Board Of Trustees Of The Leland Stanford Junior University | WD-40 derived peptides and uses thereof |
US5935803A (en) * | 1994-02-01 | 1999-08-10 | Terrapin Technologies, Inc. | Methods to identify immunomodulators using cognate interaction of PKC-theta |
US5783405A (en) * | 1994-02-01 | 1998-07-21 | Terrapin Technologies, Inc. | Rapid screening method for effectors of signal transduction |
US5776716A (en) * | 1994-02-01 | 1998-07-07 | Terrapin Technologies, Inc. | Methods for identifying agents which block the interaction of fyn with PKC-theta, and uses thereof |
US6423684B1 (en) | 1994-02-01 | 2002-07-23 | The Board Of Trustees Of The Leland Stanford Junior University | WD-40 derived peptides and uses thereof |
AU2004203423B2 (en) * | 1995-10-10 | 2008-04-10 | Stanford University | Methods to identify modulators of cell signalling |
WO1997017437A2 (en) * | 1995-11-10 | 1997-05-15 | Cedars-Sinai Medical Center | A chromosome 21 - derived nucleic acid encoding a novel protein, compositions and method using same |
US6054286A (en) * | 1996-06-18 | 2000-04-25 | Telik, Inc. | Methods to identify immunomodulators using cognate interaction of PKC-theta |
CA2263942A1 (en) * | 1996-08-22 | 1998-02-26 | Children's Medical Center Corporation | Novel osteopontin derived chemotactic peptides and methods of use |
US5858683A (en) * | 1996-08-30 | 1999-01-12 | Matritech, Inc. | Methods and compositions for the detection of cervical cancer |
EP0948542B1 (de) | 1996-09-11 | 2007-07-04 | Oregon Health Sciences University | Kalzium-aktivierte kaliumkanäle mit niedriger und mittlerer leitfähigkeit und ihre verwendungen. |
WO1998017299A1 (en) * | 1996-10-18 | 1998-04-30 | The Board Of Trustees Of The Leland Stanford Junior University | Isozyme-specific activators of protein kinase c, methods and compositions |
US20020137890A1 (en) * | 1997-03-31 | 2002-09-26 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
US5846777A (en) * | 1997-06-26 | 1998-12-08 | Incyte Pharmaceuticals, Inc. | Two cDNAs encoding WD-40 proteins |
US6573094B1 (en) | 1997-10-16 | 2003-06-03 | Baylor College Of Medicine | F-box genes and proteins |
FR2774378A1 (fr) * | 1998-01-30 | 1999-07-30 | Inst Nat Sante Rech Med | PROTEINE HUMAINE BETA-TrCP DE CIBLAGE DES PROTEINES VERS LES VOIES DE DEGRADATION PAR LE PROTEASOME |
FR2774377B1 (fr) * | 1998-01-30 | 2004-06-18 | Inst Nat Sante Rech Med | Proteine humaine beta-trcp de ciblage des proteines vers les voies de degradation par le proteasome |
US6555522B1 (en) * | 1998-02-05 | 2003-04-29 | Mount Sinai School Of Medicine Of The City Of New York | Peptides and other small molecules derived from regions of interacting proteins and uses thereof |
GB9807848D0 (en) * | 1998-04-09 | 1998-06-10 | Medical Res Council | Assay method and means |
US6376467B1 (en) | 1998-10-09 | 2002-04-23 | The Regents Of The University Of California | Use of inhibitors of protein kinase C epsilon to treat pain |
US20050079558A1 (en) * | 1998-08-28 | 2005-04-14 | New York University | Methods to identify compounds useful for the treatment of proliferative and differentiative disorders |
US20060088846A1 (en) * | 1998-08-28 | 2006-04-27 | Michele Pagano | Methods to identify compounds useful for the treatment of proliferative and differentiative disorders |
US6720181B1 (en) * | 1998-08-28 | 2004-04-13 | New York University | Ubiquitin ligases as therapeutic targets |
AU779893B2 (en) * | 1998-12-10 | 2005-02-17 | Signal Pharmaceuticals, Llc | Human ubiquitin ligase E3 for the modulation of NF-Kappa B |
WO2000040609A1 (fr) * | 1998-12-28 | 2000-07-13 | Kyowa Hakko Kogyo Co., Ltd. | Nouvelle proteine |
US20050048614A1 (en) * | 2000-06-13 | 2005-03-03 | Children's Medical Center Corporation | Biosynthetic oncolytic molecules and uses therefor |
IL156778A0 (en) * | 2001-01-05 | 2004-02-08 | Univ New York | Methods to identify compounds useful for the treatment of proliferative and differentiative disorders |
JP4115838B2 (ja) | 2001-01-18 | 2008-07-09 | ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ | δPKCの活性化および阻害のためのペプチド |
US7033790B2 (en) | 2001-04-03 | 2006-04-25 | Curagen Corporation | Proteins and nucleic acids encoding same |
US20030207276A1 (en) * | 2002-03-21 | 2003-11-06 | Ken-Shwo Dai | Human G protein beta subunit 1-related gene variant associated with lung cancers |
WO2003082211A2 (en) * | 2002-03-27 | 2003-10-09 | The Regents Of The University Of California | Synergy of dopamine d2 and adenosine a2 receptors activates pka signaling via beta/gamma dimers |
JP2005073621A (ja) * | 2003-09-01 | 2005-03-24 | Japan Science & Technology Agency | 脳腫瘍マーカーと脳腫瘍の診断方法 |
US20090062208A1 (en) * | 2007-02-06 | 2009-03-05 | Mochly-Rosen Daria D | Methods for maintaining blood-brain barrier integrity in hypertensive subjects using a delta-PKC inhibitor |
US20090318351A1 (en) * | 2008-03-12 | 2009-12-24 | Kevin Grimes | Method of treating acute st-elevation myocardial infarction with a delta pkc antagonist |
WO2010019965A1 (en) * | 2008-08-15 | 2010-02-18 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for modulating epsilon protein kinase c-mediated cytoprotection |
WO2010117078A1 (ja) * | 2009-04-10 | 2010-10-14 | 東亞合成株式会社 | 神経分化誘導ペプチド及びその利用 |
EP2497784B1 (de) * | 2009-11-02 | 2016-01-06 | Toagosei Co., Ltd | Peptid zur förderung einer zellproliferation und verwendung davon |
US8822408B2 (en) | 2010-06-04 | 2014-09-02 | Toagosei Co., Ltd. | Cell growth-promoting peptide and use thereof |
US9238796B2 (en) | 2010-06-04 | 2016-01-19 | Toagosei Co. Ltd. | Cell growth-promoting peptide and use thereof |
US9370182B2 (en) | 2012-05-28 | 2016-06-21 | Toagosei Co., Ltd. | Antimicrobial peptide and use thereof |
WO2014061749A1 (ja) | 2012-10-18 | 2014-04-24 | 東亞合成株式会社 | 2型tnf受容体の発現を抑制する合成ペプチド及びその利用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5283173A (en) | 1990-01-24 | 1994-02-01 | The Research Foundation Of State University Of New York | System to detect protein-protein interactions |
US5352660A (en) | 1991-10-31 | 1994-10-04 | Mount Sinai Hospital Corporation | Method for assaying for a substance that affects a SH2-phosphorylated ligand regulatory system |
US5519003A (en) | 1994-02-01 | 1996-05-21 | Board Of Trustees Of The Leland Stanford Junior University | WD-40-derived peptides and uses thereof |
-
1994
- 1994-02-01 US US08/190,802 patent/US5519003A/en not_active Expired - Lifetime
-
1995
- 1995-01-31 AT AT95911591T patent/ATE430801T1/de not_active IP Right Cessation
- 1995-01-31 EP EP95911591A patent/EP0742824B1/de not_active Expired - Lifetime
- 1995-01-31 WO PCT/US1995/001210 patent/WO1995021252A2/en active Search and Examination
- 1995-01-31 JP JP7520680A patent/JPH09511390A/ja active Pending
- 1995-01-31 CA CA002182299A patent/CA2182299A1/en not_active Abandoned
- 1995-01-31 DE DE69535948T patent/DE69535948D1/de not_active Expired - Lifetime
- 1995-06-07 US US08/473,089 patent/US6342368B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US5519003A (en) | 1996-05-21 |
WO1995021252A3 (en) | 1995-10-05 |
AU1910095A (en) | 1995-08-21 |
EP0742824A1 (de) | 1996-11-20 |
JPH09511390A (ja) | 1997-11-18 |
US6342368B1 (en) | 2002-01-29 |
EP0742824B1 (de) | 2009-05-06 |
DE69535948D1 (de) | 2009-06-18 |
WO1995021252A2 (en) | 1995-08-10 |
CA2182299A1 (en) | 1995-08-10 |
AU706585B2 (en) | 1999-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE430801T1 (de) | Von wd-40 abstammende peptide und ihre verwendung | |
KR970702917A (ko) | Lag-3의 가용성 폴리펩타이드 절편 및 생산 방법, 치료 조성물, 항-이디오타입 항체 | |
ATE368053T1 (de) | Antimikrobielle peptide | |
EA200100447A1 (ru) | Гибридные белки на основе бета-интерферона и их применение | |
CA2270289A1 (en) | Proteins with enhanced levels of essential amino acids | |
ATE173275T1 (de) | Von einem retrovirus aus der hiv-gruppe abgeleitete peptide und deren verwendung | |
DE3486154D1 (de) | Cardiodilatin, ein neues peptidhormon und verfahren zu seiner herstellung. | |
DE68927379D1 (de) | Plättchen blockierende peptide | |
DE69331501T2 (de) | Unterdrückung der Proliferation von T-Zellen mittels Peptidfragmenten des basischen Proteins aus Myelin | |
DK0479912T3 (da) | Fremgangsmåde til hæmning af N-endereglens forløb i levende celler | |
CA2249180A1 (en) | Methods for recombinant microbial production of bpi-fusion proteins and bpi-derived peptides | |
DE69715181T2 (de) | Peptid der löslichen form von acetylcholinesterase mit aktivität als calciumkanalmodulator | |
ES2058479T3 (es) | Compuestos peptidicos. | |
DE69229718D1 (de) | Mutierte Form von dem Beta-Amyloidprecursor Proteine Gen | |
DE69333952D1 (de) | Klonering von dem gen für das t gondii protein gp 28.5 peptidfragmente aus diesem protein und ihre verwendungen. | |
ATE190318T1 (de) | Pcna bindende substanz | |
WO1996002572A3 (fr) | Sequence polypeptidique antigenique du facteur viii, fragments et/ou epitopes de celle-ci | |
WO1999002708A8 (en) | Fusion proteins comprising sequences derived from bovine if1 atpase inhibitor protein | |
DE69832299D1 (de) | Einkettigen polypeptiden enthalten troponin i und troponin c | |
DE59109235D1 (de) | Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung | |
AU2676399A (en) | Novel cystine knot protein and materials and methods for making it | |
ATE317851T1 (de) | Polypeptide mit aminosäuresequenzen aus dem n- terminalen bereich von gp116 von cytomegalovirus und deren verwendung bei der diagnostik, prophylaxe und therapie | |
ATE224403T1 (de) | Verwendung von kaseinfragmenten als wachstumerförderer | |
ATE432985T1 (de) | Polypeptide mit aktivität der stimulierung von neutrophilen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |